Amgen Inc. AMGN: Absurd That This Stock Sells for 14x Earnings

February 14, 2025

Amgen Inc. (NASDAQ: AMGN) has been making waves in the pharmaceutical industry with its breakthrough drugs and innovative research. However, it seems that investors might be overlooking the potential of this stock. A recent analysis by industry experts at Stocks Prognosis reveals that Amgen is currently trading at just 14 times its earnings, which is considered to be significantly undervalued.

Amgen has a strong pipeline of blockbuster drugs and potential breakthrough treatments in various stages of development. With a focus on oncology, immunology, and cardiovascular diseases, the company is expected to continue its impressive growth trajectory. Investors should take note of this opportunity and consider adding Amgen to their portfolio.

Despite its promising outlook, some investors might be hesitant to buy Amgen shares due to concerns over its upcoming dividend. However, dividend investors should not be too quick to dismiss the company. Amgen has a solid track record of consistently increasing its dividend payout over the years, and its upcoming dividend is expected to follow suit.

To make an informed decision about the future movement of Amgen's stock, it is recommended to consult with professionals from Stocks Prognosis. Their expertise in analyzing market trends and predicting stock movements can provide valuable insights for investors looking to capitalize on the potential growth of Amgen Inc.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

Amgen's strong pipeline and potential growth in the oncology and cardiovascular sectors make it a compelling investment. I'll definitely consider adding it to my portfolio

— from MarketMason at 02-17-2025 15:08

I'm a long-term investor and I'm definitely considering adding Amgen to my portfolio. Their focus on oncology and cardiovascular diseases shows great potential

— from CharlotteCampbell at 02-17-2025 09:39

I'm not convinced that Amgen's upcoming dividend will be as promising as the article suggests. I'll need to see more evidence before making a decision

— from RiskyRita at 02-17-2025 07:32

Amgen's focus on breakthrough treatments and innovative research makes it an exciting stock to watch. I'm looking forward to seeing how it performs in the future

— from OliverHayes at 02-17-2025 01:12

Amgen's undervaluation and consistent dividend growth make it an attractive investment option. I'll definitely do more research on this stock

— from CarterPatterson at 02-16-2025 12:00

I trust Stocks Prognosis' analysis and if they say that Amgen is undervalued, then I believe it. I'm going to keep an eye on this stock

— from NicholasEdwards at 02-16-2025 09:32

I've been looking for a pharmaceutical stock with growth potential and Amgen seems like a solid choice. I'll definitely do more research on their pipeline

— from CashKendra at 02-16-2025 04:15

I've been following Amgen for a while and I'm excited to see their strong pipeline of drugs. This undervalued stock seems like a great investment opportunity

— from CashCasey at 02-16-2025 02:21

It's impressive to see that Amgen is trading at just 14 times its earnings. This undervaluation makes it an attractive investment

— from NoraJenkins at 02-15-2025 22:50

Although Amgen has a strong pipeline, I'm concerned about the competition in the pharmaceutical industry. I'll wait for more information before investing

— from PennyParker at 02-15-2025 12:52

I've been a long-time investor in the pharmaceutical industry and Amgen's potential has caught my attention. I'm optimistic about its future prospects

— from JessicaMoore at 02-15-2025 06:34

I'm not sure if Amgen's growth trajectory will continue as expected. The industry is unpredictable and there are always risks involved

— from BrittanyClark at 02-14-2025 22:21

Amgen's track record of consistently increasing its dividend payout is a good sign for dividend investors. I might consider adding this stock to my portfolio

— from EquityEmma at 02-14-2025 12:16

I trust Stocks Prognosis' expertise and their recommendation to consult with them for insights on Amgen's future movement. I'll definitely reach out to them for more information

— from ProfitPiper at 02-14-2025 11:41

If you want to leave a comment, then you need Login or Register

Other news for AMGN

April 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025 ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

March 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

March 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

March 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

March 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....

Related news

December 2, 2024AbbVie Inc. ABBV: A Promising Pharmaceutical Stock with Underrated Potential ~2 min.

AbbVie Inc. (ABBV), a renowned pharmaceutical company, has been gaining attention as one of the most undervalued pot stocks in the market....

January 1, 2025Is Bristol-Myers Squibb Co. the Game-Changer in the Pharma Industry? ~2 min.

Bristol-Myers Squibb Company (BMY), a renowned pharmaceutical giant, has been making significant strides in the industry....

January 22, 2025Bristol Myers Squibb Stock Shows Resilience in a Volatile Market ~2 min.

Amidst a volatile stock market, Bristol Myers Squibb (BMY) has managed to maintain its stability and even show some gains....

January 22, 2025Vertex Pharmaceuticals Incorporated VRTX Leading the Trend: What You Should Know ~2 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has been making waves in the stock market recently, attracting the attention of investors....

December 18, 2024AbbVie Inc. ABBV to Acquire Nimble Therapeutics in a Game-Changing Move ~1 min.

AbbVie Inc., a leading biopharmaceutical company, has announced its acquisition of Nimble Therapeutics, a pioneer in the field of immunology....

Search on StockPrognosis.com

Sections of the site

Amgen Inc. AMGN: Absurd That This Stock Sells for 14x Earnings

Find out how the AMGEN INC. rate is expected to change

Investor opinions & comments:

Other news for AMGN

Related news

Stocks-Prognosis.com © 2025